Why the study?
Does percutaneous transluminal coronary angioplasty alter plasma hemostatic markers in patients with chronic coronary artery disease?
Population
75 patients with chronic coronary artery disease
Comparison
Percutaneous transluminal coronary angioplasty vs Baseline (before PTCA)
Design
Cohort
Follow-up
1 day
Authors
Loading...
PTCA may transiently heighten early thrombotic risk in chronic CAD; leaves open any link to restenosis and requires prospective confirmation.
Does percutaneous transluminal coronary angioplasty alter plasma hemostatic markers in patients with chronic coronary artery disease?
PTCA induces transient changes in hemostatic markers, suggesting an initial activation of the coagulation system followed by an improvement in the hypercoagulable state, which may be related to the risk of coronary restenosis.
Saito et al. (1999) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: